ProteomEdge

📍 Stockholm, Sweden🗓 Founded 2023👥 5 employees💰 Last funded Jan 2023
Biotechnology Research🌐 proteomedge.com
Website LinkedIn
ProteomEdge™ is a company from Stockholm, Sweden, with a mission to bring precision into MS-based absolute quantification of blood plasma proteins. Our proprietary analysis platform offers cleavable heavy-isotope labeled protein standards for targets of both clinical and research interests that is versatile and easy to use. The technology ensures state-of-the-art accuracy in absolute protein quantification using mass spectrometry within a unique format that allows for addition-only protocols and straightforward handling in fully automated pipelines. Our products offer various protein panels for multiplexed analysis of human blood plasma proteins delivered in prealiquoted 96-well plates. This elegant setup outlines a new strategy for unbiased discoveries and confident results. ApoEdge - Multiplex panel for absolute quantification of all Apolipoproteins https://proteomedge.com/ae1801/
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in ProteomEdge?
ProteomEdge has 1 investors on record on gritt.io, including 1 early-stage backers.
When did ProteomEdge last raise funding?
The most recent investment in ProteomEdge recorded on gritt.io was in January 2023.
When was ProteomEdge founded?
ProteomEdge was founded in 2023.
What industry is ProteomEdge in?
ProteomEdge operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ProteomEdge based?
ProteomEdge is headquartered in Stockholm, Sweden.